Feed

This review aims to raise awareness of the Allergic Rhinitis and its Impact on Asthma (ARIA) and European Forum for Research and Education in Allergy and Airway Disease (EUFOREA) guidelines for allergic rhinitis (AR) by presenting a side-by-side summary of their key elements. Drawing on the authors' direct involvement in the development of both, it highlights their evolution toward precision medicine and patient-centred care to support stronger doctor-patient partnerships.

Both ARIA and EUFOREA offer evidence-based guidance to support AR management, with increasing emphasis on personalisation and digital integration. While aligned in goals, they differ in patient classification, treatment delivery, and implementation strategies. Barriers to real-world use include the need for contextual adaptation, targeted education for healthcare providers and patients, and inconsistent alignment between guideline-based prescriptions and patient behaviour. Mobile health (mHealth) tools offer valuable support but require sustained engagement. Greater awareness of these guidelines can improve implementation, harmonise treatment approaches, and ultimately enhance care delivery and outcomes for individuals with AR.